PSN-491

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePSN-491
Drug Alias Namedual DPP IV inhibitor/GPR119 agonist (Prosidion)PSN-IV/119-1DIVAPSN-491
ClassificationSmall molecules
Mechanisms of ActionGlucose-dependent insulinotropic receptor modulatorsDipeptidyl peptidase IV inhibitors
TargetsGlucose-dependent insulinotropic receptorDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProsidion Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProsidion Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A